CY1115690T1 - Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων - Google Patents

Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων

Info

Publication number
CY1115690T1
CY1115690T1 CY20141100737T CY141100737T CY1115690T1 CY 1115690 T1 CY1115690 T1 CY 1115690T1 CY 20141100737 T CY20141100737 T CY 20141100737T CY 141100737 T CY141100737 T CY 141100737T CY 1115690 T1 CY1115690 T1 CY 1115690T1
Authority
CY
Cyprus
Prior art keywords
arthrospira
based compositions
subject
composition
relates
Prior art date
Application number
CY20141100737T
Other languages
English (en)
Inventor
Kelvin Winston Duncan
Peter Owen Johnston
Ashley Michael Brown
Original Assignee
Biovite Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004906317A external-priority patent/AU2004906317A0/en
Application filed by Biovite Australia Pty Ltd filed Critical Biovite Australia Pty Ltd
Publication of CY1115690T1 publication Critical patent/CY1115690T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/005—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C12N1/066—Lysis of microorganisms by physical methods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01132—Chitosanase (3.2.1.132)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01041—Chitin deacetylase (3.5.1.41)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Sustainable Development (AREA)
  • Botany (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)

Abstract

Η παρούσα εφεύρεση αφορά μία σύνθεση περιλαμβάνουσα φυσιολογικώς καταπονηθείσα Αrthrospira maxima για χρήση ως βιοκτόνο ή/και θεραπευτικό. Η εφεύρεση επίσης αφορά μέθοδο για αποτροπή ή θεραπεία μιας μόλυνσης ή προσβολής ενός υποκειμένου από έναν οργανισμό, όπου η μέθοδος περιλαμβάνει το στάδιο χορήγησης στο υποκείμενο μίας αποτελεσματικής ποσότητας μίας σύνθεσης που περιλαμβάνει φυσιολογικώς καταπονηθείσα Αrthrospira.
CY20141100737T 2004-11-03 2014-09-11 Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων CY1115690T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2004906317A AU2004906317A0 (en) 2004-11-03 Arthrospira-based Compositions and Uses Thereof
EP05799363.6A EP1814977B1 (en) 2004-11-03 2005-11-03 Arthrospira-based compositions and uses thereof

Publications (1)

Publication Number Publication Date
CY1115690T1 true CY1115690T1 (el) 2017-01-25

Family

ID=36318829

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100737T CY1115690T1 (el) 2004-11-03 2014-09-11 Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων

Country Status (17)

Country Link
US (1) US8808706B2 (el)
EP (2) EP1814977B1 (el)
JP (1) JP5117193B2 (el)
KR (1) KR101350764B1 (el)
CN (1) CN101068917B (el)
CA (1) CA2627187C (el)
CY (1) CY1115690T1 (el)
DK (2) DK2502983T3 (el)
ES (2) ES2639821T3 (el)
HK (1) HK1114876A1 (el)
NZ (1) NZ554897A (el)
PL (2) PL2502983T3 (el)
PT (1) PT1814977E (el)
RU (1) RU2412990C2 (el)
SI (1) SI1814977T1 (el)
WO (1) WO2006047830A1 (el)
ZA (1) ZA200704295B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2639821T3 (es) 2004-11-03 2017-10-30 Biovite Australia Pty Ltd Composiciones a base de Arthrospira y usos de las mismas
JP5195395B2 (ja) * 2008-12-19 2013-05-08 株式会社リコー 画像処理装置、画像処理方法、画像処理プログラム及び記録媒体
GB2472790A (en) * 2009-08-18 2011-02-23 Laurence Christian Hayes Dermatological preparations comprising microbes.
DE102011107307A1 (de) 2011-07-06 2013-01-10 Ocean Research & Development Gmbh Verfahren zur Herstellung eines pharmazeutisch wirksamen Extrakts aus Arthrospira spec.
WO2014165253A1 (en) * 2013-03-12 2014-10-09 Nbip, Llc Compositions and methods for preventing infection of a wound and for advancing the healing process
EP3065699A1 (en) * 2013-11-05 2016-09-14 Nestec S.A. Use of glucosamine-enriched plant compositions
DE102013112696A1 (de) * 2013-11-18 2015-05-21 Ocean Research & Development Gmbh Verwendung eines Extrakts aus Arthrospira spec. gegen Methicillin-resistente Staphylococcus aureus-Stämme
CN105899221B (zh) * 2013-12-23 2021-02-09 医疗品牌研究有限公司 基于藻类和橄榄叶提取物的皮肤用组合物
FR3025213A1 (fr) * 2014-08-28 2016-03-04 Algobiotech Procede d'induction de la synthese des phycobiliproteines
CN110769840A (zh) * 2017-05-23 2020-02-07 碧澳维特澳大利亚股份有限公司 源自节螺藻属的提取物及其用途
JP2019092413A (ja) * 2017-11-21 2019-06-20 株式会社タベルモ 飲食品用藻類含有組成物及びその製造方法
CN107823106A (zh) * 2017-11-28 2018-03-23 广东易康正道大健康生命科技有限公司 一种促进面部微循环及表皮修复的剃须乳液及其制备方法
CA3180598A1 (en) * 2020-06-03 2021-12-09 Biovite Australia Pty Ltd. Anti-microbial and anti-inflammatory composition comprising arthrospira extracts and an organic acid
EP3967318A1 (en) * 2020-09-14 2022-03-16 Bionou Research, S.L. Probiotic compositions for the treatment of acne

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR90002E (fr) 1963-08-16 1967-09-29 Inst Francais Du Petrole Procédé de culture d'algues en milieu synthétique
US3403471A (en) * 1965-02-18 1968-10-01 Inst Francais Du Petrole Method of culturing algae in an artificial medium
FR1557635A (el) 1967-04-20 1969-02-21
JPS5221336A (en) * 1975-08-12 1977-02-17 Kanto Taale Seihin Kk Cosmetic utilizing spirulina alga
JPS5231836A (en) 1975-09-05 1977-03-10 Ryuzo Yoshida Beauty packs containing spirulina platensis
JPS54140737A (en) * 1978-04-24 1979-11-01 Kimiko Horiie Hair tonic
JPH05112461A (ja) * 1991-07-01 1993-05-07 Nippon Oil Co Ltd 抗ウイルス性抽出物
US5443844A (en) * 1992-12-03 1995-08-22 Mcdaniel; William R. Linoleic acid preparations for topical treatment of acne vulgaris
FR2706305B1 (fr) * 1993-06-15 1995-08-25 Payot Laboratoires Dr Ng Composition cosmétique ou pharmaceutique anti-radicaux libres pour application topique.
JPH08301772A (ja) * 1995-05-01 1996-11-19 Nippon Oil Co Ltd 硫酸多糖類のカルシウム塩を含んで成る抗ウイルス剤
JPH0967265A (ja) * 1995-08-31 1997-03-11 Nippon Oil Co Ltd 魚類病原ウイルスに対する抗ウイルス剤
AU742294B2 (en) 1996-12-09 2001-12-20 Biovite Australia Pty Limited A method of biological control
NZ328013A (en) 1997-06-04 1999-06-29 Cellular Improvements Ltd Subs Method and apparatus for preparing an homogenous mixture of disrupted biological cells by using a rapid pressure change of an inert gas
CN1265566A (zh) * 1997-06-04 2000-09-06 细胞改良有限公司 破碎生物材料的方法和装置
FR2768744B1 (fr) * 1997-09-19 2000-10-13 Quoc Kiet Pham Procede de culture mixotrophique de spirulines pour la production d'une biomasse riche en acides gras polyinsatures omega 6 et/ou en sulfolipides
DE10059107A1 (de) 1999-12-23 2001-06-28 Henkel Kgaa Extrakt aus der Blaualge Spirulina und seine Verwendung in kosmetischen und dermatologischen Mitteln zur Haut- und Körperpflege
JP2001224332A (ja) * 2000-02-15 2001-08-21 Minoru Yoneda 歯周疾患対応食品
MD2516C2 (ro) 2004-04-07 2005-03-31 Валериу РУДИК Remediu medicamentos antiinflamator, antiseptic şi antifungic sub formă de gel
ES2639821T3 (es) 2004-11-03 2017-10-30 Biovite Australia Pty Ltd Composiciones a base de Arthrospira y usos de las mismas

Also Published As

Publication number Publication date
ZA200704295B (en) 2008-08-27
DK1814977T3 (da) 2014-09-29
CA2627187C (en) 2015-12-08
CN101068917A (zh) 2007-11-07
JP2008518977A (ja) 2008-06-05
ES2503340T3 (es) 2014-10-06
EP1814977A1 (en) 2007-08-08
HK1114876A1 (en) 2008-11-14
KR20070092214A (ko) 2007-09-12
WO2006047830A1 (en) 2006-05-11
PL1814977T3 (pl) 2014-12-31
EP1814977B1 (en) 2014-06-18
NZ554897A (en) 2008-11-28
PL2502983T3 (pl) 2017-11-30
EP2502983A1 (en) 2012-09-26
PT1814977E (pt) 2014-09-23
RU2007120514A (ru) 2008-12-10
CA2627187A1 (en) 2006-05-11
SI1814977T1 (sl) 2014-11-28
EP2502983B1 (en) 2017-06-07
RU2412990C2 (ru) 2011-02-27
DK2502983T3 (en) 2017-09-25
ES2639821T3 (es) 2017-10-30
EP1814977A4 (en) 2009-11-11
US8808706B2 (en) 2014-08-19
US20090123429A1 (en) 2009-05-14
JP5117193B2 (ja) 2013-01-09
CN101068917B (zh) 2010-12-15
KR101350764B1 (ko) 2014-02-19

Similar Documents

Publication Publication Date Title
CY1115690T1 (el) Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων
CY1120102T1 (el) Συνθεσεις και μεθοδοι για μειωση τριγλυκεριδιων χωρις αυξηση επιπεδων ldl-c σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
CY1114617T1 (el) Αμινοτετραϋδροπυρανια ως αναστολεις διπεπτιδυλο πεπτιδασης-iv για την αγωγη ή προληψη διαβητη
EA200802213A1 (ru) Способы лечения заболеваний крови
CY1117757T1 (el) Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους
CY1119269T1 (el) Θεραπεια βλαβων που προκαλουνται απο ιους
EA201001639A1 (ru) Композиции и способы их получения и применения
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
EA200970575A1 (ru) Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения
MX2009008439A (es) Nuevos inhibidores de la replicacion del virus de hepatitis c.
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
CY1117326T1 (el) Παραγωγο κατεχολαμινης χρησιμο για τη θεραπεια ασθενειας parkinson
EA201100873A1 (ru) Пиридилоксииндолы - ингибиторы vegf-r2 и их применение для лечения заболевания
EA201100794A1 (ru) Замещенные пиримидины, предназначенные для лечения заболеваний, таких как рак
EA201071264A1 (ru) Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера
UA107783C2 (en) Isoindoline compounds for use in treating cancer
EA200870569A1 (ru) Соединения и способы модуляции fxr
CY1116494T1 (el) Θεραπευτικη αγωγη θρομβοεμβολικων διαταραχων με ριβαροξαβανη
EA201791669A2 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
EA201000098A1 (ru) Производные хиназолинамида
EA201100255A1 (ru) 5-алкинилпиримидины
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
ATE412636T1 (de) Piperazinylpyridinderivate als mittel gegen adipositas